• Subscribe
  • Newsfeed
  • About
Announce News

Laverock Therapeutics

To add a bio or update company history, please click update information.

News from Laverock Therapeutics

    Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapiesLaverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies
    Laverock Therapeutics
    1 Jul 2025

    Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

    Laverock Therapeutics is developing programmable gene control technologies that enable advanced therapies to respond dynamically to disease, improving precision, safety and effectiveness in cell-based treatments.

Laverock Therapeutics
  • Life Sciences
  • London, United Kingdom
  • £20m
  • laverocktx.com
  • Update Information

More venture news

  • Outpost Bio secures a £2.6m pre-seed round led by Merantix Capital and Seedcamp to make human microbiology computable
    Outpost Bio
    2 Mar 2026

    Outpost Bio secures a £2.6m pre-seed round led by Merantix Capital and Seedcamp to make human microbiology computable

    Pre-seedLife Sciences
  • Sonas Pharma secures pre-seed funding led by SFC Capital to develop therapeutics for obesity and epilepsy
    Sonas Pharma
    25 Feb 2026

    Sonas Pharma secures pre-seed funding led by SFC Capital to develop therapeutics for obesity and epilepsy

    Pre-seedLife Sciences
  • Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs
    Allos AI
    13 Jan 2026

    Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn